Stem cell research has been as controversial as it has been beneficial.The biggest discovery to date is the ability for stem cell therapy to heal injuries and provide pain relief for several chronic conditions.
With many professional athletes already using stem cell therapy to recover from injuries, stem cells have gained increased acceptance.
Using this finding as a launch pad, stem cell therapy now is being considered for treatment of serious conditions from heart disease to Alzheimers. Its worth taking a few moments to see just how much potential stem cell therapy has and how much progress has already been made.
Prolotherapy is a non-surgical treatment option for serious health conditions. An irritant is directly injected at a injury site and kick-starts the bodys natural immune response.
| Related: Singer Glen Campbells Inspirational Alzheimers Battle |
Stem cell therapy falls under this type of treatment and is commonly used for pain relief with back and joint problems. These treatment options are preferred because of their non-invasive nature and the benefit for painful nerves, joints, tissues, and muscles.
Stem cell therapy involves specifically using the individuals own cells to repair any damage or injury. Stem cells have proven to be very beneficial to our health and well-being.
These cells give rise to the unspecialized cells and vital organs in our body. Using them allows cells to be replaced that have been removed through injury, damage, or just normal wear and tear.
Research has shown that stem cell therapy can bring many beneficial improvements, such as:
Reduced healing time for wounds and injuries
Pain reduction without the need for mediations
Increased flexibility, range of motion, and functionality of joints
Increased collagen production
Prevention of scar tissue formation
Prevention of hair loss
Decreased nerve damage from injury
Reduced muscle compensation and risk of repeat injuries
The stem cells used are typically removed from the brown (adipose) fat in the body or the bone marrow. The cells are placed in centrifuge machines to isolate and concentrate the most valuable components.
| Related: How New Research May Overhaul Our Response to Strokes |
Seven different types of growth factor are included in this mixture. These cells are injected directly into the damaged, injured, or painful area of tissue, allowing the growth factors to get to work creating new cells and connective tissue.
The unspecialized nature of stem cells makes them very powerful. They can be removed from one part of the body and delivered to another without rejection. They can transform into whatever cell they need to be to perform the desired function.
Stem cells can become brain cells, heart tissue cells, red blood cells, or muscle cells depending on what you need.
The concentration of growth factors is what allows stem cells to perform their job quickly. Their presence accelerates the natural repair response within your body, meaning you get reduced healing time.
The direct application to the injured or damaged area also means that medications are no longer needed. They take too long to reach the scene and come with negative side effects anyway.
| Related: Why the Latest Cancer Test Led to Worldwide Excitement |
You get quick and efficient relief and repair with stem cell therapy. Their ability to divide and reproduce quickly allows them to deliver relief right away. Even when they have been inactive for a period of time, they get to work quickly, and you experience the benefits in a short amount of time.
A typical treatment plan can last between one week and three months, but even if you end up in it for the long haul, you will feel the difference after one or two sessions
The success of stem cell therapy in treating painful injuries has been such a success that research continues to see where else it can be useful. The properties and regeneration powers of stem cells make them probable candidates for treatments of serious conditions, such as heart disease or cognitive decline.
With many of these conditions having limited treatment options, a natural and more efficient therapy would be ideal. Here are the 5 top benefits of stem cell therapy:
Mesenchymal cells have been found to differentiate into bone, cartilage, tendon, and muscle tissues. When derived from the bone marrow, these cells can facilitate bone repair and cartilage replacement.
| Related: Natural Ways to Boost Bone Healing |
You can benefit from reduced chronic pain, improved functionality, and healed stubborn injuries. The best part is that there is no risk of tumor development, because the cells have a proliferation check procedure in place.
Once the cells start to physically touch each other, growth stops, so you will never end up with more than you need or uncontrolled division.
Heart disease is characterized by oxygen-deprived heart tissue, which in turn causes scarring. You end up with dangerous blood pressure and blood flow changes.
Stem cell therapy is being used to improve recovery for heart disease patients by stimulating the repair and growth of damaged blood vessels and decreasing the formation of scar tissue, so blood flow is not impacted.
Transplanted stem cells have been shown to help with the formation of new brain cells in cases of Alzheimers, Parkinsons, and stroke. By improving synaptic connections and slowing degeneration, stem cell therapy slows the progression of these diseases.
| Related: New Study Finds Key to Detecting Alzheimers Early |
The presence of the new brain cells promotes regulation of dopamine levels, which helps to ward off degeneration. In stroke victims specifically, these cells replace neurons that were damaged, allowing for brain activity and communication to continue, along with better brain health.
With autoimmune disorders such as diabetes, the body attacks its own cells. Stem cells can proliferate and produce the cells that are needed.
In the case of diabetes, the insulin-producing cells that are destroyed can be replaced, allowing for the regulation of blood sugar and control over diabetes.
The most recent application of stem cell therapy has been in the fight against MS. Currently, there is no cure for this degenerative condition, so any advancement is necessary.
A faulty immune system is the cause of this disease, so chemotherapy is required to kill the faulty system first. Stem cells are then injected back into the blood to rebuild the immune system. Research in this field is new but continues to be promising.
Stem cell therapy has been a focal point of scientific research for decades. Advances have already been seen, from simple pain relief to the development of viable treatment options for serious health conditions.
With sights set on helping those that suffer from incurable diseases and life-altering pain, stem cell therapy and research continues to drive forward, offering relief, repair, and a new start for many. Its definitely worth having a look.
Continued here:
5 Stem Cell Therapy Benefits for Heart Disease, Joint Pain ...
- The therapeutic potential of stem cells - PubMed Central (PMC) - November 12th, 2024
- Stem Cell Therapy Market Is Projected To Achieve A Market Value Of USD 3.40 Bn. By 2030, Reflecting A Robus... - WhaTech - October 18th, 2024
- Doctor who provided ineffective stem cell therapies disciplined 6 years after investigation began - CBS Chicago - October 15th, 2024
- Study reveals the benefits and downside of fasting - Big Think - September 28th, 2024
- Tiny vesicles from umbilical cord blood may have therapeutic benefit - Parkinson's News Today - September 28th, 2024
- The Stem Cell Solution Review: Is This Program the Future of Anti-Aging and Recovery? - Enumclaw Courier-Herald - September 28th, 2024
- Cell and Gene Therapy Research To Benefit From New Stem Cell Collection Center - Technology Networks - September 25th, 2024
- Stem Cell Restore: A Full Review of Its Role in Promoting Regeneration and Vitality - Islands' Sounder - September 18th, 2024
- Is fasting good for you? A new study reveals some hidden risks and benefits of the practice - Business Insider India - August 31st, 2024
- Study reveals the benefits and downside of fasting - MIT News - August 27th, 2024
- Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain - August 22nd, 2024
- Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Niclas Lindstedt - August 22nd, 2024
- PharmaTher’s Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine’s Potential to Bind to Monkeypox (Mpox) Proteins - August 22nd, 2024
- BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY... - August 22nd, 2024
- Eyenovia Announces Pricing of $5.14 Million Public Offering - August 22nd, 2024
- Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management... - August 22nd, 2024
- Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment - August 22nd, 2024
- SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® - August 22nd, 2024
- MDxHealth Reports Q2 and Half Year 2024 Results - August 22nd, 2024
- Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country - August 22nd, 2024
- Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of... - August 22nd, 2024
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility - August 22nd, 2024
- Certara to Participate in Upcoming Investor Conferences - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Satu Ahomäki - August 22nd, 2024
- Bavarian Nordic Announces First Half 2024 Results - August 22nd, 2024
- BioCryst to Present at Upcoming Investor Conferences - August 22nd, 2024
- Zymeworks Announces Participation in Upcoming Investor Conferences - August 22nd, 2024
- MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update - August 14th, 2024
- Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan - August 14th, 2024
- Shock Top and Gator Athletics Partner to Introduce First-Ever Craft Beer Sponsorship of the Florida Athletic Department - August 14th, 2024
- IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update - August 14th, 2024
- Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - August 14th, 2024
- Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders - August 14th, 2024
- Evaxion Announces Business Update and Second Quarter 2024 Financial Results - August 14th, 2024
- Galera Announces Board Approval of Complete Liquidation and Dissolution - August 14th, 2024
- Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update - August 14th, 2024
- Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - August 14th, 2024
- Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research - August 14th, 2024
- CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update - August 14th, 2024
- Panavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer Medicine - August 14th, 2024
- Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - August 14th, 2024
- Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005 - August 14th, 2024
- Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic... - August 14th, 2024
- Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results - August 14th, 2024
- Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - August 14th, 2024
- Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis - August 14th, 2024
- Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates... - August 14th, 2024
- What Is Stem Cell Therapy? How Does It Work? - ThePrint - August 6th, 2024
- New Study Shows Short-Term Benefits of Stem Cell Therapy for MS Patients, But Long-Term Efficacy Remains Unclear - Managed Healthcare Executive - July 26th, 2024
- Cord Blood Awareness Month: Advantages of cord blood banking, things to keep in mind - Moneycontrol - July 10th, 2024
- Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System - Frontiers - June 28th, 2024
- Harnessing benefits of stem cells for heart regeneration | ASU News - ASU News Now - June 21st, 2024
- 'Didn't know this would be possible': Autistic teen's mom on stem cell therapy benefits - WZTV - May 6th, 2024
- John Cleese says he's been spending 17,000 annually on stem cell therapy to 'buy a few extra years' - Yahoo News UK - April 24th, 2024
- Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH - Scrip - April 24th, 2024
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
Recent Comments